Baird Financial Group
AMAG

Baird Financial Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Baird Financial Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,021
Closed -$185K – 1306
2017
Q3 		$185K Buy
+10,021
New +$187K ﹤0.01% 1188
2017
Q2 		– Sell
-9,736
Closed -$220K – 1268
2017
Q1 		$220K Buy
+9,736
New +$233K ﹤0.01% 1142
2015
Q4 		– Sell
-5,606
Closed -$223K – 1298
2015
Q3 		$223K Buy
5,606
+352
+7% +$21.8K ﹤0.01% 1130
2015
Q2 		$363K Buy
+5,254
New +$331K ﹤0.01% 1070

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baird Financial Group's AMAG Position: Q4 2017 in Review

Baird Financial Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 10,021 shares — an estimated $185K sold.

Baird Financial Group first reported a position in AMAG in Q2 2015 and held it in 4 quarters. The position peaked at $363K in Q2 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

  • Baird Financial Group reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Baird Financial Group sold 10,021 AMAG Pharmaceuticals shares in Q4 2017, an estimated $185K.
  • Baird Financial Group first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Baird Financial Group's AMAG Pharmaceuticals position peaked at $363K in Q2 2015.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Baird Financial Group's 13F filing for Q4 2017, filed 9 Feb 2018.